Neonatal streptozotocin-induced rat model of type 2 diabetes mellitus: A glance

Indian Journal of Pharmacology

Volumn 36, Issue 4, 2004, Pages 217-221

  Arulmozhi, D K ^a,b   Veeranjaneyulu, A ^a   Bodhankar, S L ^b  

^a LUPIN LIMITED   (India)

^b BHARATI VIDYAPEETH DEEMED UNIVERSITY   (India)

Author keywords

Beta cells; Hyperglycemia; Insulin; NIDDM

Indexed keywords

STREPTOZOCIN;

ANIMAL MODEL; ARTICLE; CARBOHYDRATE METABOLISM; CONTROLLED STUDY; DIABETIC ANGIOPATHY; DISEASE SIMULATION; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; IMPAIRED GLUCOSE TOLERANCE; INSULIN RELEASE; INSULIN RESPONSE; LIPID METABOLISM; NEWBORN; NEWBORN DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; PROTEIN METABOLISM; RAT; RAT STRAIN; STREPTOZOCIN DIABETES; VASCULAR DISEASE;

EID: 4444319488     PISSN: 02537613     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Pickup JC and Williams G, editors. Textbook of diabetes. 3rd Ed, USA: Blackwell Science Ltd 2003.
2. Keen H, Ng Tang Fui S. The definition and classification of diabetes mellitus. Clin Endocrinol Metab 1982;11:279-305.
3. Ziv E, Shafrir E, Kalman R, Galer S, Bar-On H. Changing patterns of prevalence of insulin resistance in Psammomys obesus, a model of nutritionally-induced Type 2 diabetes. Metabolism 1999;48:1549-54.
4. Corsetti JP, Sparks JD, Peterson RG, Smith RL, Sparks CE. Effects of dietary fat on the development of non-insulin dependant diabetes mellitus in obese Zucker diabetic fatty male and female rat. Atherosclerosis 2000;48:231-41.
5. Russell JC, Graham SE, Dolphin PJ. Glucose tolerance and insulin resistance in the JCR:LA Cp rat. Effect of miglitol (Bay M1099). Metabolism 1999;48:701-6.
6. Zavatoni I, Bonni L, Fantuzzi M, Dallaglio E, Passerri M, Reaven GM. Hyperinsulinemia, obesity and syndrome X. J Intern Med 1994;235:51-6.
7. k) in obese spontaneously hypertensive Koletsky rat (SHORB). J Nutr 1998;128:2299-306.
8. Burcelin R, Kamohara S, Li J, Tannenbaum GS, Charron MJ, Friedmen JM. Acute intravenous leptin infusion increases glucose turnover but not skeletal muscle glucose uptake in ob/ob mice. Diabetes 1999;48:1264-9.
9. y mice. Eur J Endocrinol 1998;139:654-61.
10. Mori S, Kawano K, Hirashima T. Relationship between diet control and the development of spontaneous Type II diabetes and diabetic neuropathy in OLETF rats. Diabetes Res Clin Prac 1996;33:145-52.
11. Zangen SW, Yagil C, Zangen DH, Ornoy A, Jacob HJ, Yagil Y. The newly inbred Cohen diabetic rat. A non obese normolipidemic genetic model of diet induced Type 2 diabetes expressing sex differences. Diabetes 2001;50:2521-9.
12. Lown JN, Mc Laughlin LW, Chang Y. Mechanisms of action of 2-halo ethyl nitrosoureas on DNA and its relations to their anti-leukemic properties. Bioorg Chem 1979;7:97-110.
13. Doux SP, Woodley SE, Patton NJ, Wilson GL. Mechanism of nitrosourea induced β cell damage: Alteration in DNA. Diabetes 1986;35:866-72.
14. Portha B, Blondel O, Serradas P, Mc Evoy R, Girox MH, Kergoat, et al. The rat models of non-insuin dependant diabetes induced by neonatal streptozotocin. Diabete Metab 1989;15:61-75.
15. Okamato H. Regulation of proinsulin synthesis in pancreatic islets and a new aspect to insulin dependant diabetes. Mol Cell Biochem 1981;37:43-61.
16. Okamato H, Takaswa S. Recent advances in the Okamato model the cyclic ADP-Ribose signal system and the regulating gene protein (Reg)-Reg receptor system in β cells. Diabetes 2002;51 (Suppl. 3):462-73.
17. Masiello P, Broca C, Gross R, Roye M, Manteghetti M, Hillarire-Buys D, et al. Experimental NIDDM: Development of a new model in adult rats administered streptozotocin and nicotinamide. Diabetes 1998;47:224-9.
18. Larsen MO, Rolin B, Wilken M, Carr RD, Goffredsen DF. Measurements of insulin secretory capacity and glucose intolerance to predict pancreatic β cell mass in vivo in the nicotnamide/streptozotocin Göttingen mini pig, a model of moderate insulin deficiency and diabetes. Diabetes 2003;52:118-23.
19. Fierabracci V, De Tata V, Pocai A, Novelli M, Barbora A, Masiello P. Oral tungstate treatment imporves only transiently alteration of glucose metabolism in new rat model of type 2 diabetes. Endocrine 2002;19:177-84.
20. Rebel U, Larsen MO, Rolin B, Carr RD, Wilken M, Sturis J, et al. NN221: A long-acting glucagons-like peptide-1 derivative with antidiabetic in glucose tolerant pigs. Eur J Pharmacol 2002;451:217-25.
21. Novelli M, Fabregat ME, Fernandez-Alvarez J, gomis R, Masiello P. Metabolic and functional studies on isolated islets in a new rat model of type 2 diabetes. Mol Cell Endocrinol 2001;175:57-66.
22. Portha B, Levancher C, Picolon L, Rosselin G. Diabetogenic effect of streptozotocin in the rat during the prenatal period. Diabetes 1974;23:883-95.
23. Portha B, Picolon L, Rosselin G. Chemical diabetes in the adult rat as the spontaneous evolution of neonatal diabetes. Diabetologia 1979;17:371-7.
24. Junod A, Lambert AE, Stanffacher W, Reynold AE. Diabetogenic action of streptozotocin: relationship of the dose to metabolic response. J Clin Invest 1969;48:2129-39.
25. Oliver B, Daniel B, Portha B. Relation of insulin deficiency to impaired insulin action in NIDDM adult rat given streptozotocin as neonates. Diabetes 1989;38:610-17.
26. Bonnier-Weir S, Trent DE, Honey RN, Weir GC. Response to neonatal islets to streptozotocin: Limited β cell regeneration and hyperglycemia. Diabetes 1981;30:64-9.
27. Weir GC, Clore EE, Zma-Chinsky CJ, Bonnier-Weir S. Islet secretion in new experimental model for non-insulin dependant diabetes. Diabetes Metabolism Rev 1981;30:590-5.
28. Daniel Porte JR. β cells in type 2 diabetes mellitus. Diabetes 1991;40:116-80.
29. Matthews DR. Physiological implications of pulsatile hormone secretion. Ann NY Acad Sci 1991;618:28-37.
30. Charles JG, Donnia JK, David SW, David MM. Decrease insulin and glucagons pulse amplitude accompanying β cell deficiency induced by streptozotocin in Baboons. Diabetes 1989;38:925-31.
31. Lang DA, Matthews DR, Burnett M, Turner RE. Brief irregular oscillation of basal plasma insulin and glucose concentration in diabetic man. Diabetes 1981;30:43-9.
32. Polonsky KS, Given BD, Hirsch I, Tillil H, Sharpiro ET, Beebe C, et al. Abnormal patterns of insulin secretion in non-insulin dependant diabetes mellitus. N Eng J Med 1988;318:1231-9.
33. Girox MH, Portha B, Kergoat M, Bailbe D, Picon L. Glucose insensitivity and amino acid hypersensitivity of insulin release in rat with non-insulin dependant diabetes. A study with perfused pancreas. Diabetes 1983;32:445-51.
34. Hellerstorm C, Anderson A, Gunnarsson R. Regeneration of islet cells. International symposium on the immunological aspects of diabetes. Acta Endocrinol 1976;(Suppl.205):145-58.
35. Weir GC, Leahy JL, Bonnier Weir S. Experimental reduction of B cell mass: Implications for the pathogenesis of diabetes. Diabetes Metabolism Rev 1986;2:125-61.
36. Kergoat M, Portha B. In vivo hepatic and peripheral insulin sensitivity in rats with non-insulin dependent diabetes induced by streptozotocin assessment with the insulin glucose clamp technique. Diabetes 1985;34:1120-6.
37. Reaven GM, Sageman WS, Swenson RS. Development of insulin resistance in normal dogs following alloxan induced insulin deficiency. Diabetologia 1983;25:273-9.
38. Gerich JE. Assessment of insulin resistance and its role in non-insulin dependent diabetes mellitus. J Lab Clin Med 1984;103:497-505.
39. Kruszynska YT, Homee PD. Liver and muscle insulin sensitivity, glycogen concentration and glycogen synthase activity in rat model of non-insulin dependent diabetes. Diabetologia 1998;31:304-39.
40. Frantus IG, Chayoth R, O'dea L, Marliss E, Yale JE, Grose M. Insulin binding and glucose transport in adipocytes in neonatal streptozotocin injected rat models of diabetes mellitus. Diabetes 1987;36:654-60.
41. Trent PF, Fletneer DJ, May JM, Bonnier-Wir SGC. Abnormal islet and adipocyte function in young β cell deficient rats with normoglycemia. Diabetes 1984;33:170-5.
42. Maloff BL, Boyd BK. Physiologic and cellular insulin action in glucose intolerant models of type 2 (non-insulin dependent) diabetes in the rat. Diabetologia 1986;29:295-300.
43. Takeshi O, Noboru F, Fumiliko Y, Korekiyo W. JTT-608 controls blood glucose by enhancement of glucose stimulated insulin secretion in normal and diabetes mellitus rats. Eur J Pharmacol 1999;367:91-9.
44. Lee HW, Park YS, Choi JW, Yi SY, Shin WS. Antidiabetic effects of chitosan oligosaccharides in neonatal streptozotocin-induced non insulin dependent diabetes mellitus rats. Biol Pharm Bull 2003;8:1100-3.
45. Tormo MA, Leon-Quinto T, Saulnier C, Bailbe D, Serradas P, Portha B. Insulin secretion and glucose tolerance after islet transplantation in rats with non insulin dependent diabetes-induced by neonatal streptozotocin. Cell Transplantation 1997;6:23-32.
46. Morin L, Girox MH, Gangnerau, MN, Bailbe D, Portha B. Impaired phosphoinositide metabolism of glucose incompetent islets of neonatally streptozotocin-diabetic rats. Am J Physiol 1997;272:737-45.
47. Dachicourt N, Serradas P, Bailbe D, Kergoat M, Doare L, Portha B. GLP-1(7-36) amide confers glucose sensitivity to previously glucose-incompetent β cells in diabetic rats. In vivo and in vitro studies. J Endocrinol 1997;155:369-76.
48. Shinde UA, Mehta AA, Goyal RK. Effect of chronic treatment with Bis (maltoloto) oxavanadium (VI) in rat model of non-insulin-dependent-diabetes. Indian J Exp Biol 2001;9:864-70.